CSL - Equity Capital And Reserves

Stock Price
146.54
Daily Change
0.52 0.35%
Monthly
-18.68%
Yearly
-43.76%
Q1 Forecast
150.05

CSL reported $21.41B in Equity Capital and Reserves for its fiscal semester ending in June of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Arca Biopharma USD 486.79M 143.15M Sep/2025
aTyr Pharma USD 80.24M 5.58M Sep/2025
Bio Path USD -7.16M 4.57M Jun/2025
Brainstorm Cell Therapeutics USD -7.69M 1.64M Sep/2025
Cara Therapeutics USD 32.93M 41M Jun/2025
CSL USD 21.41B 861M Jun/2025
Curis USD -13.99M 7.38M Jun/2025
Esperion Therapeutics USD -451.36M 17.85M Sep/2025
Immunic USD 10.5M 23.41M Sep/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Minerva Neurosciences USD -34.58M 2.47M Sep/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024